Health Care & Life Sciences » Pharmaceuticals | Eyegate Pharmaceuticals Inc.

Eyegate Pharmaceuticals Inc.

Eyegate Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$11.37 M
Shares Outstanding
45.58 M
Public Float
36.14 M


271 Waverley Oaks Road
Waltham Massachusetts 02452
United States
Employees -
Updated 07/08/2019
EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.


View All

Paul G. Chaney
Stephen From
President, Chief Executive Officer & Director